Neutralizing RNS May Improve Immunotherapy Outcomes

09:39 EDT 31 Oct 2018 | Life Extension Advocacy Foundation

Researchers at the University of Notre Dame discovered that amino acid nitration can inhibit the activation of T cells employed in immunotherapy against cancer and that suppression of reactive nitrogen species (RNS) responsible for nitration can significantly boost the effectiveness of immunotherapy [1]. Abstract Potent immunosuppressive mechanisms within the tumor microenvironment contribute to the resistance...

Original Article: Neutralizing RNS May Improve Immunotherapy Outcomes

More From BioPortfolio on "Neutralizing RNS May Improve Immunotherapy Outcomes"